Results for the six months ended 30 September 2022
2
Overview
Jonathan Murphy
CEO
Results for the six months ended 30 September 2022
Assura's long-term position of strength
Critical demand for investment in NHS infrastructure
Strong balance sheet and long dated debt book
3
High quality
portfolio
Sustainability
credentials
underpin our
offering
Results for the six months ended 30 September 2022
4
Well-positioned to navigate short-term challenges
Macro-economic headwind
Volatility in debt and
equity markets
Barriers to external growth
Downward pressure on
valuations
Unstable macro-economic
backdrop
Assura well-positioned
Debt book 100% fixed at 2.3%, 7.5 year maturity
£284m cash and available facilities
Quality portfolio provides scope for value adding asset enhancements
Good level of inflation protection - 4.5% average annual uplift achieved in first half
Historical valuations stable with long-term secure underpinning
Significant covenant headroom
Healthcare demand is not cyclical
81% of income underpinned by NHS
Results for the six months ended 30 September 2022
5
Sustainability approach as a key differentiator
Sustainability credentials underpin offering
NHS targeting Net Zero Carbon by 2045
Increasing trend for community health services and social prescribing
47% EPC B Targeting 100% by Mar-26
Net zero across entire portfolio by 2040
6 million patients benefitting from SixBySix strategy by Mar-26
ESG-linked
financing
Assura
Community
Sustainable
Fund has
investor
deployed
returns
over £1.3m
since 2020
Buildings that
First NZC
facilitate delivery
development
of health services
on site -
bespoke to each
Fareham
community
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Assura plc published this content on 22 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 November 2022 07:25:02 UTC.
Assura plc is a United Kingdom-based real estate investment trust (REIT). The Company specializes in the development of, investment in and management of a portfolio of primary care, diagnostic and treatment buildings across the United Kingdom. It develops new buildings, invests in existing buildings, manages portfolios, and ultimately, owns them for the long term. It also designs, builds, invests in, and manages GP surgery, primary care, and community healthcare buildings so the NHS has the places and spaces it needs to deliver more services, tests, and treatments in the community. The Company owns and manages a portfolio of about 612 properties. The Companyâs subsidiaries include Assura (SC1) Ltd, BHE (St James) Ltd, Assura PCP UK Ltd, Metro MRI Ltd, Upton Community Health Care Ltd, Cheltenham Family Health Care Centre Ltd, Upton Medical Ltd, Xantaris Investments (XXI) Ltd, Assura Services Ltd, Assura Primary Care Properties Ltd, Assura Trellech Ltd, and others.